VEGFA and renal cell adenocarcinoma: The IMDC (International Metastatic RCC Database Consortium) score developed, during the anti-VEGF era, includes clinical parameters such as performance status, hemoglobin, calcium levels, and neutrophil and platelet counts to predict patient prognosis [11].